Public-Private Partnerships | Takeda Pharmaceuticals
Our Public-Private Partnerships (PPP) extend beyond traditional biological approaches and integrate the latest technological advances, such as artificial intelligence and machine learning. Our Global Science Policy work helps identify and contribute focus on which PPPs to engage with to help us understand, anticipate and influence future scientific trends and policies better.
Our PPPs and Global Science Policy work have a shared purpose. Through this work, we assess and shape policy, and facilitate and lead collaborations, which bolster our ability to responsibly translate science into highly innovative, life-changing therapies and vaccines.
We coordinate with our other policy functions on the following R&D policy priorities:
Elevate Patients' Role
Elevate the role of the patient in drug development, with a particular focus on representation of patient populations from rare disease and underserved communities.
Advance innovative scientific approaches to drug development, including charting development paths for cell and gene therapies.
Leverage All Available Data
Leverage all relevant and available data in drug development, with an initial focus on real world data and analytics.
Regulatory Processes & Collaboration
Streamline regulatory processes and collaboration, with an initial focus on developing cloud platforms for efficient data sharing with regulators.